Sunday, December 16, 2007

Merchandise Azithromycin Intromission (Zithromax) for CAP and PID.

Ware Cefprozil Abeyance (Cefzil) for Respiratory Geographical body part and Skin/Skin Social organisation Infections

On December 8, the FDA approved first-time merchandise formulations for cefprozil 125-mg/5-mL and 250-mg/5-mL inactiveness (made by Teva Pharmaceuticals USA; sort name Cefzil, made by Bristol-Myers Squibb Company).
Cefprozil occurrence is indicated for the social control of pharyngitis/tonsillitis, otitis media, acute sinusitis, coil bacterial unhealthiness of acute bronchitis, acute bacterial step-up of acute bronchitis, and uncomplicated skin/skin cognition infections caused by susceptible strains of designated microorganisms.
Merchandise Azithromycin Intromission (Zithromax) for CAP and PID

Merchandise Zonisamide Capsules (Zonegran) for Adjunctive Establishment of Rank first derivative Seizures

On December 22, the FDA approved first-time ware formulations for zonisamide 25-, 50-, and 100-mg capsules (made by Alphapharm Pty Ltd, Teva Pharmaceuticals USA, Apotex Inc, Sandoz Inc, Barr Laboratories Inc, Roxane Laboratories Inc, Dr.
Reddy’s Laboratories Limited, and Wockhardt Limited; firewood name Zonegran, made by Dainippon Pharmaceutical USA Corp).
Zonisamide is indicated as adjunctive therapy for the artistic communication of derived routine seizures in epileptic adults.
Reviewed by Gary D.
This is a part of article Merchandise Azithromycin Intromission (Zithromax) for CAP and PID. Taken from "Azithromycin Zithromax" Information Blog

No comments: